FDA
approval
· 2019-02-19
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Hisun Pharmaceuticals USA Inc.)
Summary
FDA approved a supplemental application for Irbesartan and Hydrochlorothiazide by Hisun Pharmaceuticals USA Inc., updating the product's labeling and approval.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)